VIDEO: Bayer Faces Law Suits In United States Over Xarelto: Paper
Citing company sources, the Frankfurter Allgemeine Zeitung newspaper reported on Saturday said, Germany's Bayer faces its first law suits in the United States over anti-clotting drug Xarelto, one of its top five medicines. A Bayer spokesman declined to comment on the newspaper's report but said the drug's safety profile since its launch is consistent with the results of clinical studies that involved more than 75,000 patients. Bayer peer Boehringer Ingelheim last month said it would pay about $650 million to settle U.S. lawsuits that claimed the company's blockbuster blood thinner, Pradaxa, had caused severe and fatal bleeding in patients.